What is the relationship between malignant tumors and C-reactive protein?

Jul 15, 2025 Source: Cainiu Health
Dr. Qi Zhirong
Introduction
During the progression of malignant tumors, tumor cells may stimulate the body to produce an inflammatory response, or the tumor may be accompanied by infection or tissue necrosis, which can prompt the liver to synthesize C-reactive protein (CRP), leading to elevated levels. In such cases, increased CRP levels can serve as a reference indicator for tumor activity or disease progression and are associated with the extent of tumor development.

Generally, malignant tumors may cause elevated C-reactive protein (CRP) levels, but an increase in CRP does not necessarily indicate the presence of a malignant tumor. If abnormalities are detected, timely medical consultation is recommended. Detailed explanation is as follows:

During the progression of malignant tumors, tumor cells may stimulate the body's inflammatory response, or elevated CRP levels may occur when the tumor is complicated by infection or tissue necrosis. In such cases, increased CRP levels can serve as a reference indicator for tumor activity or disease progression and may be associated with the extent of tumor development.

Elevated CRP levels are more commonly seen in benign conditions such as infections, trauma, and autoimmune diseases. Inflammatory responses caused by these conditions can also lead to increased CRP levels. Therefore, elevated CRP alone cannot be used to diagnose malignant tumors. A comprehensive evaluation combining other diagnostic tests is necessary to avoid misjudging the condition.

When abnormal CRP levels are detected, further examinations should be conducted in combination with clinical symptoms to determine the underlying cause. It is inappropriate to interpret the condition based solely on this single parameter.

Related Articles

View All